Budak, G. Et Al. 2022. Preclinical toxicity test results of a new antiviral–immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data). Exploration of Medicine , vol.3 , 1-21.

Budak, G., ÖZKAN, S., BUDAK, M., ŞEKER, T., MERYEMOĞLU, B., Miran, Ş. S., ... Çoban, C. Ç.(2022). Preclinical toxicity test results of a new antiviral–immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data). Exploration of Medicine , vol.3, 1-21.

Budak, Gürer Et Al. "Preclinical toxicity test results of a new antiviral–immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data)," Exploration of Medicine , vol.3, 1-21, 2022

Budak, Gürer Et Al. "Preclinical toxicity test results of a new antiviral–immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data)." Exploration of Medicine , vol.3, pp.1-21, 2022

Budak, G. Et Al. (2022) . "Preclinical toxicity test results of a new antiviral–immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data)." Exploration of Medicine , vol.3, pp.1-21.

@article{article, author={Gürer Budak Et Al. }, title={Preclinical toxicity test results of a new antiviral–immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data)}, journal={Exploration of Medicine}, year=2022, pages={1-21} }